Citation Impact
Citing Papers
Potential etiologic and functional implications of genome-wide association loci for human diseases and traits
2009 Standout
Association of Trypanolytic ApoL1 Variants with Kidney Disease in African Americans
2010 StandoutScience
A RASSF1A-HIF1α loop drives Warburg effect in cancer and pulmonary hypertension
2019 StandoutNobel
Wild-type PCSK9 inhibits LDL clearance but does not affect apoB-containing lipoprotein production in mouse and cultured cells
2005
N-linked glycosylation of macrophage-derived PAF-AH is a major determinant of enzyme association with plasma HDL
2001
Variation in the PPARα gene is associated with altered function in vitro and plasma lipid concentrations in Type II diabetic subjects
2000
Thiazolidinediones
2004 Standout
ω-6 Polyunsaturated fatty acids extend life span through the activation of autophagy
2013 StandoutNobel
Improved nonalcoholic steatohepatitis after 48 weeks of treatment with the PPAR-γ ligand rosiglitazone
2003
Peroxisome Proliferator-activated Receptor α Negatively Regulates the Vascular Inflammatory Gene Response by Negative Cross-talk with Transcription Factors NF-κB and AP-1
1999
PPARγ Activation Primes Human Monocytes into Alternative M2 Macrophages with Anti-inflammatory Properties
2007
MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity
2006 Standout
Inflammation and metabolic disorders
2006 StandoutNature
Cardiovascular Effects of Intensive Lifestyle Intervention in Type 2 Diabetes
2013 Standout
Ulcerative Colitis
2011 Standout
Mechanisms Underlying Inflammation in Neurodegeneration
2010 Standout
Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation
2006 StandoutNature
Prospects for Cardiovascular Research
2001 StandoutNobel
Prevalence of Obesity and Trends in Body Mass Index Among US Children and Adolescents, 1999-2010
2012 Standout
Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1/TSC2 tumor suppressor complex
2004 StandoutNobel
Peroxisome proliferator-activated receptors (PPARs): Nuclear receptors at the crossroads between lipid metabolism and inflammation
2000
Design and validation of a histological scoring system for nonalcoholic fatty liver disease†
2005 Standout
Reduction of Atherosclerosis by the Peroxisome Proliferator-activated Receptor α Agonist Fenofibrate in Mice
2002
Macrophages in the Pathogenesis of Atherosclerosis
2011 Standout
Adipocytes as regulators of energy balance and glucose homeostasis
2006 StandoutNature
Induction of IκBα Expression as a Mechanism Contributing to the Anti-inflammatory Activities of Peroxisome Proliferator-activated Receptor-α Activators
2000
The changing landscape of atherosclerosis
2021 StandoutNature
Magnesium Replacement Improves the Metabolic Profile in Obese and Pre-Diabetic Patients with Mild-to-Moderate Chronic Kidney Disease: A 3-Month, Randomised, Double-Blind, Placebo-Controlled Study
2017 Standout
Requirement of PPARα in maintaining phospholipid and triacylglycerol homeostasis during energy deprivation
2004
Human nutrition, the gut microbiome and the immune system
2011 StandoutNature
Macrophage-specific PPARγ controls alternative activation and improves insulin resistance
2007 StandoutNature
Micronised Fenofibrate
2002
Peroxisome proliterator-activated receptor-alpha activators regulate genes governing lipoprotein metabolism, vascular inflammation and atherosclerosis
1999
Graves' Ophthalmopathy
2010 Standout
Lipid-droplet-accumulating microglia represent a dysfunctional and proinflammatory state in the aging brain
2020 StandoutNobel
PPAR-α and PPAR-γ activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway
2001
Delayed catabolism of apoB-48 lipoproteins due to decreased heparan sulfate proteoglycan production in diabetic mice
2000
Simple Combinations of Lineage-Determining Transcription Factors Prime cis-Regulatory Elements Required for Macrophage and B Cell Identities
2010 Standout
Inflammation in Hypertension
2020
Peroxisome proliferator-activated receptor and retinoid X receptor ligands inhibit monocyte chemotactic protein-1-directed migration of monocytes
2000
Combinatorial roles of nuclear receptors in inflammation and immunity
2005
Inflammation in atherosclerosis
2002 StandoutNature
Peroxisome Proliferator-activated Receptor-γ Ligands Inhibit Adipocyte 11β-Hydroxysteroid Dehydrogenase Type 1 Expression and Activity
2001
Origin and physiological roles of inflammation
2008 StandoutNature
Evolving knowledge and therapy of inflammatory bowel disease
2006
Hepatitis C Virus Entry
2007 StandoutNobel
Trypanosome Lytic Factor, an Antimicrobial High-Density Lipoprotein, Ameliorates Leishmania Infection
2009
The hormone resistin links obesity to diabetes
2001 StandoutNature
Biochemistry and molecular cell biology of diabetic complications
2001 StandoutNature
Mechanisms for Insulin Resistance: Common Threads and Missing Links
2012 Standout
Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c
2004
Progress and challenges in translating the biology of atherosclerosis
2011 StandoutNature
Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies
2009 Standout
Resveratrol Improves Mitochondrial Function and Protects against Metabolic Disease by Activating SIRT1 and PGC-1α
2006 Standout
The NS5A Protein of Hepatitis C Virus Is a Zinc Metalloprotein
2004 StandoutNobel
Hypochlorite-oxidized low-density lipoprotein upregulates CD36 and PPARγ mRNA expression and modulates SR-BI gene expression in murine macrophages
2005
Mechanisms of disease: pulmonary arterial hypertension
2011
Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
2010 Standout
Hepatitis C Virus NS5A Colocalizes with the Core Protein on Lipid Droplets and Interacts with Apolipoproteins
2002
Atherosclerosis
2001 Standout
Sequence Variations in PCSK9, Low LDL, and Protection against Coronary Heart Disease
2006 Standout
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease
2011 StandoutNature
Bifidobacteria can protect from enteropathogenic infection through production of acetate
2011 StandoutNature
Roles of PPARs in health and disease
2000 StandoutNature
Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial
2005 Standout
The Role of the High-Density Lipoprotein Receptor SR-BI in the Lipid Metabolism of Endocrine and Other Tissues
2003
Expression of CD68 and Macrophage Chemoattractant Protein-1 Genes in Human Adipose and Muscle Tissues
2005
Enhancement of Docetaxel Anticancer Activity by a Novel Diindolylmethane Compound in Human Non–Small Cell Lung Cancer
2009
Autoregulation of the Human Liver X Receptor α Promoter
2001
Bis- and Trisindolylmethanes (BIMs and TIMs)
2009 Standout
Nuclear Receptors and Lipid Physiology: Opening the X-Files
2001 StandoutScience
The Mechanisms of Action of PPARs
2002 Standout
The role of inflammation in vascular diseases
2000
Common Pathological Processes and Transcriptional Pathways in Alzheimer's Disease and Type 2 Diabetes
2009
Improved Nonalcoholic Steatohepatitis After 48 Weeks of Treatment With the Ppar–γ Ligand Rosiglitazone
2003
Regulation of Macrophage Functions by PPAR-α, PPAR-γ, and LXRs in Mice and Men
2008
HUMAN IMMUNITY TO THE MENINGOCOCCUS
1969 Standout
PPARα Activators Inhibit Tissue Factor Expression and Activity in Human Monocytes
2001
A Transgenic Model of Visceral Obesity and the Metabolic Syndrome
2001 StandoutScience
Human Platelets Secrete the Plasma Type of Platelet-Activating Factor Acetylhydrolase Primarily Associated With Microparticles
2006
Pleiotropic Actions of Peroxisome Proliferator–Activated Receptors in Lipid Metabolism and Atherosclerosis
2002
The peroxisome proliferator-activated receptorγ (PPARγ) as a regulator of monocyte/macrophage function
1999
REDD2 Gene Is Upregulated by Modified LDL or Hypoxia and Mediates Human Macrophage Cell Death
2004
The PPARs: From Orphan Receptors to Drug Discovery
2000 Standout
Peroxisome Proliferator-Activated Receptors: Nuclear Control of Metabolism*
1999 Standout
Activation of Peroxisome Proliferator-Activated Receptor γ Does Not Inhibit IL-6 or TNF-α Responses of Macrophages to Lipopolysaccharide In Vitro or In Vivo
2000
Hepatocyte Nuclear Factor 4α (Nuclear Receptor 2A1) Is Essential for Maintenance of Hepatic Gene Expression and Lipid Homeostasis
2001
Phospholipase A2Enzymes: Physical Structure, Biological Function, Disease Implication, Chemical Inhibition, and Therapeutic Intervention
2011 Standout
Effect of Peroxisome Proliferator-Activated Receptor Alpha Activators on Tumor Necrosis Factor Expression in Mice during Endotoxemia
1999
PPARα Agonists Inhibit Tissue Factor Expression in Human Monocytes and Macrophages
2001
Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults--The Evidence Report. National Institutes of Health.
1998 Standout
Human Atherosclerotic Plaque Alternative Macrophages Display Low Cholesterol Handling but High Phagocytosis Because of Distinct Activities of the PPARγ and LXRα Pathways
2011
Phosphorylation of hepatitis C virus nonstructural protein 5A modulates its protein interactions and viral RNA replication
2004 StandoutNobel
Emerging roles of PPARS in inflammation and immunity
2002
Works of M Antonucci being referenced
Overexpression of Human Apolipoprotein A-II in Mice Induces Hypertriglyceridemia Due to Defective Very Low Density Lipoprotein Hydrolysis
1999
Activation of Proliferator-activated Receptors α and γ Induces Apoptosis of Human Monocyte-derived Macrophages
1998
Inhibition of LPL Expression in Human Monocyte–Derived Macrophages Is Dependent on LDL Oxidation State
1998
CLA-1/SR-BI Is Expressed in Atherosclerotic Lesion Macrophages and Regulated by Activators of Peroxisome Proliferator-Activated Receptors
2000
[Agammaglobulinemia and hypogammaglobulinemia].
1958
Expression of the PAF Receptor in Human Monocyte–Derived Macrophages Is Downregulated by Oxidized LDL
1997